Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falguni Parikh

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor releasePadmini Jayaraman, Falguni Parikh, Esther Lopez-Rivera, et al.
Cancer Research|January 9, 2014
Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2Esther Lopez-Rivera, Padmini Jayaraman, Falguni Parikh, et al.
Cancer Research|August 30, 2018
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8<sup>+</sup> T Cells in Head and Neck CancerSri Krishna, Peaches Ulrich, Eric Wilson, et al.
Oncoimmunology|October 6, 2018
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapyPadmini Jayaraman, Falguni Parikh, Jared M Newton, et al.
Nature Communications|January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmesMaria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.
Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.
Cancer Research|October 17, 2014
Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancerFalguni Parikh, Dorothée Duluc, Naoko Imai, et al.
Cancer Immunology Research|August 4, 2016
Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell ImmunityWenjie Yin, Dorothée Duluc, HyeMee Joo, et al.
Journal for Immunotherapy of Cancer|January 17, 2019
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapyAurelie Hanoteau, Jared M Newton, Rosemarie Krupar, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 25, 2012
Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor releasePadmini Jayaraman, Falguni Parikh, Esther Lopez-Rivera, et al.
Cancer Research|January 9, 2014
Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2Esther Lopez-Rivera, Padmini Jayaraman, Falguni Parikh, et al.
Cancer Research|August 30, 2018
Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8<sup>+</sup> T Cells in Head and Neck CancerSri Krishna, Peaches Ulrich, Eric Wilson, et al.
Oncoimmunology|October 6, 2018
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapyPadmini Jayaraman, Falguni Parikh, Jared M Newton, et al.
Nature Communications|January 31, 2015
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmesMaria Soledad Sosa, Falguni Parikh, Alexandre Gaspar Maia, et al.
Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.
Cancer Research|October 17, 2014
Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancerFalguni Parikh, Dorothée Duluc, Naoko Imai, et al.
Cancer Immunology Research|August 4, 2016
Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell ImmunityWenjie Yin, Dorothée Duluc, HyeMee Joo, et al.
Journal for Immunotherapy of Cancer|January 17, 2019
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapyAurelie Hanoteau, Jared M Newton, Rosemarie Krupar, et al.
Pageof 20